Global Cancer Technology, Inc. is a fast-growing technology holding company with plans to undergo an IPO in the near future. The company has acquired patent licenses to some unique and novel technologies that can impact and shape the medical markets in which they are utilized. The company can expect to realize both short-term and long-term revenues from the commercialization of the patents. Additionally, the company is finalizing several capital equipment financing projects that will contribute to future earnings.
The company is currently undergoing a private placement of its stock. Early investors have an opportunity to grow with the company by acquiring private shares before our IPO is underway. Please contact us for a prospectus of this private offering.